Real-World Evaluation of the Safety and Effectiveness of Apixaban & Rivaroxaban Lead-in Dosing Compared to Parenteral Lead-in Dosing in the Treatment of Venous Thromboembolism: A Multi-Center Retrospective Cohort Study

Ghazwa B Korayem,1,* Omar A Alshaya,2– 4,* Nirvana Alnajjar,1 Ahad Alawad,1 Rand Alotaibi,1 Nader Bin Sheraim,5 Fatemah M Hakami,6 Ohud S Alsudyyes,6 Rahaf H Alsoghayer,6 Lina M Alhushan,6 Asma H Qudayr,6,7 Majed S Al Yami,2– 4 Omar A Almohammed6,8 1Department of Pharmacy Practice, College o...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Korayem GB, Alshaya OA, Alnajjar N, Alawad A, Alotaibi R, Bin Sheraim N, Hakami FM, Alsudyyes OS, Alsoghayer RH, Alhushan LM, Qudayr AH, Al Yami MS, Almohammed OA
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Dove Medical Press 2023-01-01
Rangatū:	International Journal of General Medicine
Ngā marau:	rivaroxaban apixaban lead-in parenteral anticoagulation venous thromboembolism recurrence
Urunga tuihono:	https://www.dovepress.com/real-world-evaluation-of-the-safety-and-effectiveness-of-apixaban--riv-peer-reviewed-fulltext-article-IJGM
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!